These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

507 related items for PubMed ID: 10565811

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of various 5-HT3 receptor antagonists, granisetron, ondansetron, ramosetron and azasetron on serotonin (5-HT) release from the ferret isolated ileum.
    Endo T, Minami M, Kitamura N, Teramoto Y, Ogawa T, Nemoto M, Hamaue N, Hirafuji M, Yasuda E, Blower PR.
    Res Commun Mol Pathol Pharmacol; 1999; 104(2):145-55. PubMed ID: 10634307
    [Abstract] [Full Text] [Related]

  • 4. Granisetron, a 5-HT3 receptor antagonist, inhibited cisplatin-induced 5-hydroxytryptamine release in the isolated ileum of ferrets.
    Endo T, Ogawa T, Hamaue N, Akita K, Hirafuji M, Minami M, Blower PR.
    Res Commun Mol Pathol Pharmacol; 1998 Jun; 100(3):243-53. PubMed ID: 9730004
    [Abstract] [Full Text] [Related]

  • 5. Cyclophosphamide increases 5-hydroxytryptamine release from the isolated ileum of the rat.
    Minami M, Ogawa T, Endo T, Hamaue N, Hirafuji M, Yoshioka M, Blower PR, Andrews PL.
    Res Commun Mol Pathol Pharmacol; 1997 Jul; 97(1):13-24. PubMed ID: 9507564
    [Abstract] [Full Text] [Related]

  • 6. Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869.
    Van Belle S, Lichinitser MR, Navari RM, Garin AM, Decramer ML, Riviere A, Thant M, Brestan E, Bui B, Eldridge K, De Smet M, Michiels N, Reinhardt RR, Carides AD, Evans JK, Gertz BJ.
    Cancer; 2002 Jun 01; 94(11):3032-41. PubMed ID: 12115394
    [Abstract] [Full Text] [Related]

  • 7. Luminal hypotonicity increases duodenal mucosal permeability by a mechanism involving 5-hydroxytryptamine.
    Nylander O, Pihl L.
    Acta Physiol (Oxf); 2006 Jan 01; 186(1):45-58. PubMed ID: 16497179
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
    Pradermdee P, Manusirivithaya S, Tangjitgamol S, Thavaramara T, Sukwattana P.
    J Med Assoc Thai; 2006 Oct 01; 89 Suppl 4():S29-36. PubMed ID: 17725140
    [Abstract] [Full Text] [Related]

  • 11. Chemical modulation of 5-HT3 and 5-HT4 receptors affects the release of 5-hydroxytryptamine from the ferret and rat intestine.
    Minami M, Tamakai H, Ogawa T, Endo T, Hamaue N, Hirafuji M, Yoshioka M, Blower PR.
    Res Commun Mol Pathol Pharmacol; 1995 Aug 01; 89(2):131-42. PubMed ID: 8556268
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Anti-emetic effect of ondansetron and granisetron after exposure to mixed neutron and gamma irradiation.
    Martin C, Roman V, Agay D, Fatôme M.
    Radiat Res; 1998 Jun 01; 149(6):631-6. PubMed ID: 9611102
    [Abstract] [Full Text] [Related]

  • 14. [Serotonin and anticancer drug-induced emesis].
    Minami M, Endo T, Hamaue N, Hirafuji M.
    Yakugaku Zasshi; 2004 Aug 01; 124(8):491-507. PubMed ID: 15297719
    [Abstract] [Full Text] [Related]

  • 15. Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma.
    Slabý J, Trnený M, Procházka B, Klener P.
    Neoplasma; 2000 Aug 01; 47(5):319-22. PubMed ID: 11130251
    [Abstract] [Full Text] [Related]

  • 16. Tropisetron, ondansetron, and granisetron for control of chemotherapy-induced emesis in Turkish cancer patients: a comparison of efficacy, side-effect profile, and cost.
    Abali H, Celik I.
    Cancer Invest; 2007 Aug 01; 25(3):135-9. PubMed ID: 17530482
    [Abstract] [Full Text] [Related]

  • 17. Ondansetron but not granisetron affect cell volume regulation and potassium ion transport of glioma cells treated with estramustine phosphate.
    Behnam-Motlagh P, Sandström PE, Henriksson R, Grankvist K.
    J Cancer Res Clin Oncol; 2002 Aug 01; 128(8):449-55. PubMed ID: 12200602
    [Abstract] [Full Text] [Related]

  • 18. 5-Hydroxyindoleacetic acid and substance P profiles in patients receiving emetogenic chemotherapy.
    Higa GM, Auber ML, Altaha R, Piktel D, Kurian S, Hobbs G, Landreth K.
    J Oncol Pharm Pract; 2006 Dec 01; 12(4):201-9. PubMed ID: 17156592
    [Abstract] [Full Text] [Related]

  • 19. Changes in serotonin metabolism in cancer patients: its relationship to nausea and vomiting induced by chemotherapeutic drugs.
    Cubeddu LX, Hoffmann IS, Fuenmayor NT, Malave JJ.
    Br J Cancer; 1992 Jul 01; 66(1):198-203. PubMed ID: 1379060
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms by which cancer chemotherapeutic drugs induce emesis.
    Cubeddu LX.
    Semin Oncol; 1992 Dec 01; 19(6 Suppl 15):2-13. PubMed ID: 1485177
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.